Merrimack Pharmaceuticals, Inc. (MACK) saw a big move last session, as the company’s shares fell more than 11% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for MACK, as the stock is now down 13.6% since May 29, 2014.
The company has seen a flat track record when it comes to current year estimate revisions over the past few weeks. The consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
MACK currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the health care sector include Actelion Ltd. (ALIOF), ANI Pharmaceuticals, Inc. (ANIP) and Gilead Sciences Inc. (GILD). All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
MERRIMACK PHARMACEUTICALS INC (MACK): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report
GILEAD SCIENCES INC (GILD): Free Stock Analysis Report
Zacks Investment Research